Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Bought by South Dakota Investment Council

South Dakota Investment Council grew its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 22.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 506,107 shares of the pharmacy operator’s stock after acquiring an additional 92,637 shares during the period. South Dakota Investment Council owned about 0.06% of Walgreens Boots Alliance worth $13,214,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of WBA. New York Life Investment Management LLC lifted its position in shares of Walgreens Boots Alliance by 0.4% during the third quarter. New York Life Investment Management LLC now owns 114,506 shares of the pharmacy operator’s stock worth $2,547,000 after purchasing an additional 499 shares during the last quarter. Fulton Bank N.A. lifted its position in shares of Walgreens Boots Alliance by 0.5% during the fourth quarter. Fulton Bank N.A. now owns 107,071 shares of the pharmacy operator’s stock worth $2,796,000 after purchasing an additional 523 shares during the last quarter. Insight Folios Inc lifted its position in shares of Walgreens Boots Alliance by 5.8% during the fourth quarter. Insight Folios Inc now owns 9,640 shares of the pharmacy operator’s stock worth $252,000 after purchasing an additional 525 shares during the last quarter. Moisand Fitzgerald Tamayo LLC lifted its position in shares of Walgreens Boots Alliance by 29.6% during the third quarter. Moisand Fitzgerald Tamayo LLC now owns 2,333 shares of the pharmacy operator’s stock worth $52,000 after purchasing an additional 533 shares during the last quarter. Finally, Pinnacle Financial Partners Inc lifted its position in shares of Walgreens Boots Alliance by 4.9% during the fourth quarter. Pinnacle Financial Partners Inc now owns 11,866 shares of the pharmacy operator’s stock worth $310,000 after purchasing an additional 555 shares during the last quarter. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari acquired 3,000 shares of the firm’s stock in a transaction that occurred on Thursday, April 11th. The stock was purchased at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the acquisition, the director now owns 3,000 shares of the company’s stock, valued at approximately $54,150. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other Walgreens Boots Alliance news, CFO Manmohan Mahajan purchased 6,000 shares of the company’s stock in a transaction that occurred on Tuesday, April 2nd. The stock was purchased at an average price of $19.38 per share, with a total value of $116,280.00. Following the completion of the transaction, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Inderpal S. Bhandari acquired 3,000 shares of the company’s stock in a transaction dated Thursday, April 11th. The shares were purchased at an average cost of $18.05 per share, with a total value of $54,150.00. Following the acquisition, the director now owns 3,000 shares of the company’s stock, valued at approximately $54,150. The disclosure for this purchase can be found here. Over the last three months, insiders acquired 13,456 shares of company stock worth $270,423. Corporate insiders own 17.40% of the company’s stock.

Walgreens Boots Alliance Stock Down 0.9 %

NASDAQ:WBA traded down $0.17 during trading hours on Tuesday, hitting $18.05. 7,275,390 shares of the stock traded hands, compared to its average volume of 14,032,324. The firm has a 50 day moving average price of $20.26 and a 200 day moving average price of $21.86. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50. Walgreens Boots Alliance, Inc. has a fifty-two week low of $17.51 and a fifty-two week high of $35.54. The firm has a market cap of $15.57 billion, a price-to-earnings ratio of -2.58, a PEG ratio of 1.13 and a beta of 0.73.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, topping analysts’ consensus estimates of $0.82 by $0.38. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The business had revenue of $37.05 billion for the quarter, compared to the consensus estimate of $35.86 billion. During the same period in the prior year, the business posted $1.16 earnings per share. Walgreens Boots Alliance’s revenue for the quarter was up 6.3% compared to the same quarter last year. Equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current year.

Analyst Ratings Changes

WBA has been the topic of a number of recent research reports. Deutsche Bank Aktiengesellschaft cut their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating on the stock in a report on Wednesday, April 3rd. Barclays initiated coverage on shares of Walgreens Boots Alliance in a report on Wednesday, January 3rd. They issued an “underweight” rating and a $21.00 target price on the stock. Truist Financial reissued a “hold” rating and issued a $25.00 target price on shares of Walgreens Boots Alliance in a report on Monday, April 1st. SVB Leerink cut their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating on the stock in a report on Monday, March 18th. Finally, UBS Group cut their target price on shares of Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating on the stock in a report on Wednesday, April 3rd. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $24.36.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.